XML 12 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Offsets
Aug. 12, 2025
USD ($)
shares
Offset: 1  
Offset Payment:  
Offset Claimed true
Rule 457(p) Offset true
Registrant or Filer Name Plus Therapeutics, Inc.
Form or Filing Type S-3
File Number 333-286393
Initial Filing Date Apr. 04, 2025
Fee Offset Claimed $ 3,688.18
Security Type Associated with Fee Offset Claimed Equity
Security Title Associated with Fee Offset Claimed Common Stock, par value $0.001 per share
Unsold Securities Associated with Fee Offset Claimed | shares 0
Unsold Aggregate Offering Amount Associated with Fee Offset Claimed $ 0.00
Offset Note A filing fee of $194,082.78 was previously paid in connection with the registration statement on Form S-3 (No. 333-286393) filed by the registrant on April 4, 2025 (the "Prior Registration Statement"). The registrant withdrew the Prior Registration Statement by filing a Form RW on June 23, 2025. As the Prior Registration Statement was not declared effective, no securities were sold thereunder. Accordingly, the full $194,082.78 filing fee previously paid in connection with the Prior Registration Statement remains available to be used to offset the fee currently due and additional fees that may become due for future registration statements. In accordance with Rule 457(p) of the Securities Act, such previously paid filing fee will offset the filing fee of $3,688.18 currently due pursuant to this registration statement.
Termination / Withdrawal Statement the Prior Registration Statement was not declared effective, no securities were sold thereunder.
Offset: 2  
Offset Payment:  
Offset Claimed false
Rule 457(p) Offset true
Registrant or Filer Name Plus Therapeutics, Inc.
Form or Filing Type S-3
File Number 333-286393
Filing Date Apr. 04, 2025
Fee Paid with Fee Offset Source $ 194,082.78